Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Q32 Bio Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 32.9K | $441K | $13.42 | Oct 15, 2024 | Direct |
Q32 Bio Inc. | Chief Scientific Officer | Common Stock | 36.3K | $264K | $7.29 | Oct 11, 2024 | By Violette Holdings LLC |
Q32 Bio Inc. | Chief Scientific Officer | Common Stock | 23.9K | $174K | $7.29 | Oct 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QTTB | Q32 Bio Inc. | Oct 11, 2024 | 5 | $58K | 4 | Oct 16, 2024 | Chief Scientific Officer |
QTTB | Q32 Bio Inc. | Oct 8, 2024 | 2 | $41.5K | 4 | Oct 10, 2024 | Chief Scientific Officer |
QTTB | Homology Medicines, Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Chief Scientific Officer |
QTTB | Homology Medicines, Inc. | Mar 25, 2024 | 0 | $0 | 3 | Mar 27, 2024 | Chief Scientific Officer |